- VX-659 and VX-445 are next gen correctors
- Correctors fix the defective CFTR protein so that it can move to the proper place on the cell surface
- Vertex expects to submit an... read more
EpicGenetics announced on9/5/18 that the U.S. Food and Drug Administration (FDA) has given approval to the Massachusetts General Hospital for a human clinical trial of BCG (an inexpensive generic... read more
Seres Therapeutics, Inc. (Nasdaq:MCRB) today announced the appointment of Meryl Zausner, a seasoned biopharmaceutical executive, to its Board of Directors. Ms. Zausner brings decades of financial... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,